Asymchem Labs

Asymchem (002821.SZ / 6821.HK) is a leading global CDMO founded in 1995 in North Carolina, U.S., providing integrated, end-to-end solutions across the pharmaceutical value chain. With R&D and manufacturing facilities in China, the U.S., and UK, and over 9,000 employees (45% in R&D), Asymchem offers development and commercial manufacturing services for small molecules, TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer.

Backed by successful USFDA and other regulatory inspections, Asymchem serves over 1,000 clients worldwide—including top 20 pharmaceutical companies and leading biotechs—supporting more than 700 clinical-stage and 40 commercial projects, all under a strong commitment to cGMP compliance and environmental health and safety (EHS).

We help accelerate drug development, reduce time to market, and deliver cost-effective, client-focused solutions.